Most hyaluronic acid tear trough filler placed in Melbourne patients persists between twelve and twenty-four months, which is typically longer than cheek or lip placement. The undereye area has very little muscle movement, limited lymphatic drainage, and low metabolic turnover in the surrounding tissue. That combination slows breakdown. Because product in this area can appear more swollen or firmer than other regions during the first month, the conservative first-session dose makes more sense than a large placement that has to settle for weeks.
What the typical range looks like
Tear trough filler typically persists longer than cheek or lip filler for the same patient. Most patients at Core Aesthetics are reviewed between twelve and eighteen months after placement, and some patients see product remaining at twenty-four months. This extended range is not a marketing claim — it reflects the particular anatomy of the undereye area.
Corey Anderson RN (AHPRA NMW0001047575) uses a conservative staged approach for first-session tear trough placement precisely because the product lasts so long in this location. A smaller initial placement that can be added to at review is usually the safer clinical choice than a larger first-session dose.
Why undereye placement persists longer than other areas
The tear trough area has three features that slow hyaluronic acid breakdown. First, minimal dynamic muscle activity — the orbicularis oculi muscle moves when blinking but the deep tear trough plane under it is comparatively static. Second, relatively sluggish lymphatic drainage around the lower eyelid. Third, a slow metabolic turnover in the thin skin and fat compartments of the undereye. All three contribute to longer persistence of placed product.
Because of this, staged placement is the default approach. Patients who request a full correction in a single session are asked to understand that product they see at week two may still be visible at year one, and that conservative dosing is the safer path.
The first month can look different from other areas
Tear trough product can appear firmer, more swollen, and sometimes slightly bluish for the first three to four weeks after placement. That is because the undereye skin is extremely thin and visible to product underneath it. The effect typically softens and integrates between weeks four and six. Any assessment of first-session results is therefore made at week six, not at week one.
This lag between placement and settled appearance is another reason the area is dosed conservatively. A patient who looks corrected at week one is often over-corrected by week six.
What the product does over the first two years
Hyaluronic acid in the tear trough typically sits as a defined bolus that gradually softens over months nine through twenty-four. The product does not disappear at a specific expiry point. Most patients report a gradual visible softening between months twelve and eighteen, with some seeing useful product remaining at twenty-four months.
The Tyndall effect — a slight bluish shadow under the skin that can appear if product is placed too superficially — typically resolves as the product integrates, though in a small number of patients it persists and is managed clinically. This is a placement-technique consideration discussed at consultation.
Typical review cadence
Patients are typically reviewed between six and eight weeks after the initial placement for a staged assessment. At that appointment the practitioner assesses whether additional conservative product is clinically appropriate. Many first-session patients return again at twelve to eighteen months for a standard maintenance review, by which point the initial placement has usually softened meaningfully.
This is different from the single-session cadence used for cheek or jaw. Tear trough is deliberately staged because the area is unforgiving of overcorrection.
What you can do to support the result
Daily broad-spectrum sun protection supports overall undereye skin quality, which influences how the filler appears over time. Adequate hydration helps general skin health in the area. Sleep quality matters more for undereye than for other filler areas — dark circles and hollowness can appear worse during periods of poor sleep even when the underlying placement is unchanged.
Patients who experience weight loss during the year after placement may notice undereye hollowness re-emerge even when molecular product is still present, because weight loss affects the adjacent fat compartments. This is a discussion at review rather than a reason to repeat product immediately.
When to return earlier than planned
Reasons to return before the expected review window include a visible firm lump under the skin, a persistent bluish tint that does not soften by week six, puffiness that worsens rather than reduces, or any sudden change in the area. These are clinical reviews rather than top-ups by default, and may result in dissolution rather than additional product.
The tear trough is the most technique-sensitive filler area on the face. Any concern in the first three months should prompt a same-day call, not a wait-and-see approach.
Is this for you?
Consider booking a consultation if
- Adults researching how long tear trough filler typically persists before planning a review appointment.
- Patients who have had undereye filler elsewhere and want to understand the conservative staged approach used at Core Aesthetics.
- Patients considering tear trough filler for the first time who want realistic duration and settling expectations.
- Patients who prefer a conservative low-volume approach to delicate-area filler.
This may not be for you if
- Patients under the age of eighteen, for whom cosmetic dermal filler is not offered at Core Aesthetics.
- Patients who are pregnant or breastfeeding, for whom elective cosmetic filler is deferred.
- Patients seeking a single large correction in the undereye area rather than a conservative staged approach.
- Patients with active skin infection, open wounds, or uncontrolled dermatological conditions around the eye.
Suitability is confirmed at consultation. This list is general guidance, not a substitute for clinical assessment.
Frequently asked questions
Does tear trough filler really last longer than cheek or lip filler?
Yes, typically. The undereye area has minimal muscle movement, slower lymphatic drainage, and lower metabolic turnover than the lip or cheek. That combination slows hyaluronic acid breakdown in the tear trough.
Can tear trough filler be placed as a single large treatment?
At Core Aesthetics the tear trough is dosed conservatively in staged sessions rather than as a single large placement. The area is unforgiving of overcorrection, and because product persists for so long, a smaller initial dose is usually the safer clinical choice.
What is the Tyndall effect and how long does it last?
The Tyndall effect is a slight bluish tint under the thin undereye skin that can appear when filler is placed too superficially. It typically resolves as the product integrates over four to six weeks. Persistent Tyndall is a clinical consideration reviewed at a follow-up.
Can I dissolve my tear trough filler if I do not like it?
Yes. Hyaluronic acid can be dissolved with an enzyme called hyaluronidase. Dissolution of tear trough filler is offered after consultation and assessment, not as a walk-in service, because the area is delicate and placement history matters.
How long before I can tell what my final tear trough result looks like?
Typically six weeks. The undereye is slower to settle than most filler areas, and initial results at week one can look firmer, more swollen, or bluer than the final integrated result. Assessment of outcome is made at week six.
Do puffy mornings mean my tear trough filler is failing?
Not necessarily. Morning puffiness can be driven by sleep, salt intake, and general fluid retention. If puffiness persists through the day or is accompanied by visible firmness or colour change, that is a reason for clinical review.
How soon after my first tear trough appointment do I come back?
Typically six to eight weeks for a staged assessment. If additional conservative product is clinically appropriate at that review it can be placed. After that, the standard twelve to eighteen month maintenance review applies.